Brief news reports on Tuberculosis

Letter to Sanofi calling for patent withdrawals on critical TB drugs

TAG and OTMeds call on Sanofi to reverse its efforts to patent two obvious combinations of two critical drugs to prevent TB: rifapentine and isoniazid.

Read More →

COVID-19 affects HIV and TB response in South Africa

A comment in The Lancet Respiratory Medicine and an article in Science reflect on the South Africa's COVID-19 response and the way it affects the response to HIV and TB in the country.

Read More →

TB Alliance announces European Commission authorisation of new treatment for highly drug-resistant TB

Pretomanid, developed by the non-profit TB Alliance, has received EU marketing authorisation in combination regimen with bedaquiline and linezolid in adults with XDR-TB or treatment-intolerant/non-responsive MDR-TB.

Read More →

Researchers are finding ‘missing’ TB patients with new, improved technology

Targeted interventions need to be shifted to patients with minimal TB symptoms in vulnerable communities, South Africa researchers say in a new study.

Read More →

RESIST-TB July 2020 newsletter

RESIST-TB released its July 2020 newsletter with the latest research publications on drug-resistant TB.

Read More →

July 2020 edition of The Union's newsletter

The International Union Against Tuberculosis and Lung Disease (The Union) released its July 2020 newsletter, summarizing the activities carried out during the month. It highlights an article, co-authored by The Union, analysing potentially devastating impact of COVID-19 lockdown on India TB deaths. The July 2020 issue of the International Journal of Tuberculosis and Lung Disease (IJTLD), the official publication of The Union, is also now available online.

Read More →

July 2020 edition of the Stop TB Partnership's newsletter

The Stop TB Partnership released its July 2020 newsletter, summarizing the initiatives and activities carried out during the month.

Read More →

Compounds show promise in search for tuberculosis antibiotics

Compounds tested for their potential as antibiotics have demonstrated promising activity against one of the deadliest infectious diseases – tuberculosis (TB).

Read More →

Scientists find new way to kill tuberculosis

The toxin can block the use of important amino acids required by the bacteria to produce essential proteins needed for survival.

Read More →

Framework for the evaluation of new tests for tuberculosis infection

29 July 2020 | GENEVA - The World Health Organization (WHO) and the Stop TB Partnership’s New Diagnostics Working Group (NDWG) launched today a framework for the evaluation of new tests for tuberculosis infection. The document provides details on study design, populations, reference standards, sample size calculation and data analysis to guide the future development of these tests.

Read More →

Page 1 of 717 · Total posts: 10

1 2 Last→